Evaluation of Routine Blood Tests for Diagnosis of Suspected Coronavirus Disease 2019
- PMID: 32902237
- DOI: 10.7754/Clin.Lab.2020.200522
Evaluation of Routine Blood Tests for Diagnosis of Suspected Coronavirus Disease 2019
Abstract
Background: Real-time reverse transcription polymerase chain reaction assay (RT-PCR) is the gold standard for diagnosis of coronavirus disease 2019 (COVID-19); however, it is not universally available and may have limitations in response times. The aim was to evaluate the routine blood tests for diagnosis of COVID-19, determining the diagnostic accuracy of blood biomarkers to differentiate between patients with and without COVID-19.
Methods: Clinical charts, nursing records, laboratory findings, and chest x-rays from adult patients with clinical suspicion of COVID-19 (fever, cough and/or dyspnea) at hospital admission were reviewed. Patients were classified into two groups according to RT-PCR COVID-19: positive (COVID-19) or negative (NON-COVID-19). Diagnostic accuracy was determined by analyzing receiver operating characteristic (ROC) curve, calculating the area under the ROC curve (AUC) and the cutoff value. In order to reduce the number of false positives, the cutoff value with a specificity of 80% was considered.
Results: Two hundred three patients (101 females, 102 males) with ages between 18 and 96 years (mean = 61.3) were studied. Ninety-four were COVID-19 and 109 were NON-COVID-19. Plasma ferritin level was the most accurate biomarker (AUC = 0.847 and 0.804 in women and men, respectively). The following diagnostic criteria for suspected COVID-19 were established with biomarker cutoff values to differentiate between COVID-19 and NON-COVID-19 patients: lymphocytes ≤ 1.0 x 109/L; eosinophils ≤ 0.02 x 109/L; ferritin > 125% of upper reference limit (URL); LDH > 125% of URL; hsCRP > 80 mg/L; and D-dimer > 1.2 mg/L. Sensitivity was 66%, 64% 62%, 46%, 43%, and 33% for ferritin, eosinophils, LDH, hsCRP, lymphocytes, and D-dimer, respectively. Of those determined to be COVID-19 patients, 91% met one or more of the diagnostic criteria with these blood biomarkers, and of the NON-COVID-19 patients, 47% did not met any diagnostic criteria.
Conclusions: Blood counts of lymphocytes and eosinophils, and plasma levels of D-dimer, LDH, hsCRP, and ferritin can be used to differentiate patients with and without COVID-19 and as a tool for diagnosis of suspected COVID-19 in adult patients at hospital admission.
Similar articles
-
Rapid identification of SARS-CoV-2-infected patients at the emergency department using routine testing.Clin Chem Lab Med. 2020 Jun 29;58(9):1587-1593. doi: 10.1515/cclm-2020-0593. Print 2020 Aug 27. Clin Chem Lab Med. 2020. PMID: 32598302
-
IL-6-based mortality risk model for hospitalized patients with COVID-19.J Allergy Clin Immunol. 2020 Oct;146(4):799-807.e9. doi: 10.1016/j.jaci.2020.07.009. Epub 2020 Jul 22. J Allergy Clin Immunol. 2020. PMID: 32710975 Free PMC article.
-
A new parameter in COVID-19 pandemic: initial lactate dehydrogenase (LDH)/Lymphocyte ratio for diagnosis and mortality.J Infect Public Health. 2020 Nov;13(11):1664-1670. doi: 10.1016/j.jiph.2020.09.009. Epub 2020 Sep 30. J Infect Public Health. 2020. PMID: 33071210 Free PMC article.
-
Thoracic imaging tests for the diagnosis of COVID-19.Cochrane Database Syst Rev. 2020 Sep 30;9:CD013639. doi: 10.1002/14651858.CD013639.pub2. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2020 Nov 26;11:CD013639. doi: 10.1002/14651858.CD013639.pub3. PMID: 32997361 Updated.
-
Correlations of Clinical and Laboratory Characteristics of COVID-19: A Systematic Review and Meta-Analysis.Int J Environ Res Public Health. 2020 Jul 13;17(14):5026. doi: 10.3390/ijerph17145026. Int J Environ Res Public Health. 2020. PMID: 32668763 Free PMC article.
Cited by
-
The Fluctuation Trend of Serum Anti-SARS-CoV-2 IgM/IgG Antibodies Seroprevalence in the Non-COVID-19 Infected Population and Correlation with Peripheral Blood Leukocyte Parameters in Beijing, China, 2021: A Real-World Study.Vaccines (Basel). 2022 Apr 7;10(4):571. doi: 10.3390/vaccines10040571. Vaccines (Basel). 2022. PMID: 35455320 Free PMC article.
-
Diagnostic value of white blood cell parameters for COVID-19: Is there a role for HFLC and IG?Int J Lab Hematol. 2022 Feb;44(1):104-111. doi: 10.1111/ijlh.13728. Epub 2021 Oct 8. Int J Lab Hematol. 2022. PMID: 34623763 Free PMC article.
-
Predicting Survival Status in COVID-19 Patients: Machine Learning Models Development with Ventilator-Related and Biochemical Parameters from Early Stages: A Pilot Study.J Clin Med. 2024 Oct 17;13(20):6190. doi: 10.3390/jcm13206190. J Clin Med. 2024. PMID: 39458141 Free PMC article.
-
Definition of the Immune Parameters Related to COVID-19 Severity.Front Immunol. 2022 Mar 18;13:850846. doi: 10.3389/fimmu.2022.850846. eCollection 2022. Front Immunol. 2022. PMID: 35371011 Free PMC article.
-
The evolving direct and indirect platforms for the detection of SARS-CoV-2.J Virol Methods. 2022 Feb;300:114381. doi: 10.1016/j.jviromet.2021.114381. Epub 2021 Nov 27. J Virol Methods. 2022. PMID: 34843826 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous